1. Home
  2. YEXT vs VSTM Comparison

YEXT vs VSTM Comparison

Compare YEXT & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

SELL

Current Price

$6.88

Market Cap

644.4M

Sector

Technology

ML Signal

SELL

VSTM

Verastem Inc.

SELL

Current Price

$8.65

Market Cap

731.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
YEXT
VSTM
Founded
2006
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
644.4M
731.8M
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
YEXT
VSTM
Price
$6.88
$8.65
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $17.22
AVG Volume (30 Days)
777.3K
★ 4.2M
Earning Date
09-01-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 131.82
17.49
EPS
★ 0.15
N/A
Revenue
★ $170,201,000.00
$30,914,000.00
Revenue This Year
N/A
$265.17
Revenue Next Year
$1.04
$45.31
P/E Ratio
$47.53
★ N/A
Revenue Growth
N/A
★ 209.14
52 Week Low
$3.27
$3.43
52 Week High
$9.03
$10.82

Technical Indicators

Market Signals
Indicator
YEXT
VSTM
Relative Strength Index (RSI) 60.19 59.36
Support Level $6.04 $5.41
Resistance Level $7.99 N/A
Average True Range (ATR) 0.23 0.76
MACD 0.03 0.05
Stochastic Oscillator 62.62 73.40

Price Performance

Historical Comparison
YEXT
VSTM

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: